With increasing information overload and packed work schedules, staying up-to-date on the newest oncologic advances is harder than ever. But take heart! The QuadShot is freshly brewed in your inbox four mornings each week so you can quickly down and digest the day's most pertinent cancer news.
A new tool to help estimate the absolute cumulative risk of contralateral breast cancer in BRCA 1/2 carriers based on age at first cancer, presence of first degree relative cancer, BRCA variant near the 3’ region, and endocrine therapy. | Sun, J Clin Oncol 2022
Comments
Post a Comment